Some drug, but probably not enough, got through For AOD9604, large molecule size wouldnt have reduced bioavailability to zero, and the use of polyethylene glycol as an excipient may have increased bioavailability slightly13, however there is the distinct possibility that not enough of the drug got through the gastrointestinal tract to make a therapeutic difference. In summation: Given the stark contrast between the biohackers and the institutional scientists, we have the selective release of fats from the fat cells in obese or lean individuals (depending on who you ask) to justify using AOD-9604 for biohacking weight loss
#1166: Q&A: New Book Release, Clean Bulking, Sleep Hacks, Supersets & More Muscle for Life with Mike Matthews 38:30 Ep
Research has also examined its role in enteric neuron survival, enteric glial cell activity, gut motility modulation, and gut-brain axis signaling in experimental settings
Thigh injections nearly halved the rate of nausea compared to abdominal injections
Regulatory status: investigational and research-only DSIP is not FDA-approved as a drug
Therapeutic doses are higher than regular doses and help quickly fill up B12 stores in the body